UGOLKEL Trademark

Trademark Overview

On Thursday, December 7, 2023, a trademark application was filed for UGOLKEL with the United States Patent and Trademark Office. The USPTO has given the UGOLKEL trademark a serial number of 79388766. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, October 21, 2024. This trademark is owned by Sumitomo Pharma Co., Ltd.. The UGOLKEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the central nervous system; cells for medical use
ugolkel

General Information

Serial Number79388766
Word MarkUGOLKEL
Filing DateThursday, December 7, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, October 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the central nervous system; cells for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSumitomo Pharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Friday, February 9, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, February 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 16, 2024APPLICATION FILING RECEIPT MAILED
Monday, July 8, 2024ASSIGNED TO EXAMINER
Monday, July 15, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 16, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 5, 2024REFUSAL PROCESSED BY MPU
Monday, August 5, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, August 25, 2024REFUSAL PROCESSED BY IB
Monday, October 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 21, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

ugolkel cells medical system nervous preparations central pharmaceutical